Developer docs
API playgroundTry for free, no card

Search company profiles

Arcadia Science

Full company profile

uuid0004i2b

Namestring
Arcadia Science
Legal namestring
Arcadia Science
Websiteurl
arcadia.science
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Arcadia Science is an evolutionary biology company developing methods to predict and test therapeutics by leveraging billions of years of evolutionary data. The company is structured around the thesis that evolution itself is the world's largest R&D program and that its structure can be used to inform every stage of the drug development cycle — from organism selection to therapeutic hypothesis generation. The platform is horizontally aimed at the scientific research community, including academics, pharmaceutical companies, and biotech researchers who need better organism models for studying human biology.

The company's core product is Zoogle, a web portal launched in February 2025 that serves as an organismal search tool. Zoogle takes evolutionary data across species and uses it to predict which organisms are the most relevant biological models for different aspects of human biology. Beyond Zoogle, Arcadia releases software pipelines, apps, protocols, and other research resources under an open-science publishing model, distributing via GitHub, Substack, blog, and social channels. The stated revenue model is subscription/recurring for its research platform and tools, though pricing is not publicly disclosed and no specific paying customers are named.

Arcadia is incorporated as a private for-profit entity based in Emeryville, California (6401 Hollis Street, Suite 100), with 11–50 employees. Its leadership is composed of co-founders Seemay Chou (CEO), Prachee Avasthi (CSO and CSA), and Jed McCaleb (Co-Founder, Board Member and Advisor to the CEO) — a configuration that combines academic biology leadership with a high-profile technology entrepreneur. Most recently, the company announced two research partnerships in August 2025 to investigate predicted disease-organism matches, representing an early step from internal research toward externally-validated, partnership-driven use of its platform.

Short descriptiontext

Arcadia Science is a private Emeryville-based evolutionary biology company building Zoogle, an organismal search tool that uses billions of years of evolutionary data to predict the best research models for human biology, serving academic, pharma, and biotech researchers via an open-science distribution model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEmeryville, United States
HQ citystring
Emeryville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
evolutionary biology research, drug discovery platform, organismal search tools, therapeutic prediction software, open science publishing
Industry2 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code1 code
  • Software Publishers5132
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Computer Programming Services7371
Product category
Drug Discovery & Biotechnology Research Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Research Platform & Tools
TypeSubscription Recurring
Description

Developing a platform for predicting and testing therapeutics based on evolutionary biology insights. The company releases tools, apps, and software pipelines to the scientific community, potentially through partnerships with pharmaceutical companies or research institutions.

arcadiascience.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Zoogle
Description

An organismal search tool that leverages billions of years of evolutionary data to help predict which organisms are the most relevant models for different aspects of human biology.

arcadiascience.com
Core offering1 text field

Arcadia Science develops Zoogle, a web portal that leverages billions of years of evolutionary data to help predict which organisms are the most relevant models for different aspects of human biology. The company is also building an evolutionary biology platform that uses the structure of evolution to inform efforts across the research and development cycle for predicting and testing therapeutics. It releases apps, software pipelines, protocols, and other resources to the scientific community as part of an open science approach.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Arcadia Science is an evolutionary biology company developing better ways to predict and test therapeutics. Their main product is Zoogle, an organismal search tool. They also offer a platform for research and development, and release various tools including apps, software pipelines, and protocols to the scientific community as part of their open science approach.

Product and service1 record
1Zoogle
CategoryDrug discovery & research software
Description

A web portal / organismal search tool that leverages billions of years of evolutionary data to help researchers predict which organisms are the most relevant models for different aspects of human biology. Intended for researchers in academic institutions, pharmaceutical companies, and biotech firms working on therapeutic prediction and model organism selection.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI-driven drug discovery platform using high-throughput biology and computational tools to identify therapeutics. Direct peer because both target therapeutic prediction through biological data and computational methods, though Recursion is much larger and more capital-intensive.

TypeDirect peer
Description

Machine learning-driven drug discovery company combining biology and AI to predict therapeutic outcomes. Comparable to Arcadia in its mission to use data-driven biology to inform drug development, though Insitro focuses on cell-based phenotypic data.

3Isomorphic Labs
TypeDirect peer
Description

Alphabet/DeepMind spinoff applying AI to drug discovery with a focus on novel protein structure prediction. A direct competitor in AI-informed therapeutic development, though with vastly greater resources and a different core methodology.

TypeDirect peer
Description

AI-native drug discovery company using graph neural networks and molecular simulation to predict drug behavior. Comparable in using computational methods to predict therapeutic properties and working with emerging biology.

TypeDirect peer
Description

AI-driven small molecule drug discovery company using structure-based design and prediction. Comparable in applying AI/ML to predict therapeutic candidates and inform R&D decisions.

TypeBroad incumbent
Description

Cloud-based life sciences R&D platform serving biotech and pharma with informatics tools. Broader incumbent in life science software, relevant as a comparator for Arcadia's software platform ambitions in the research informatics space.

TypeBroad incumbent
Description

Biomedical informatics and data management platform for genomics and clinical research. Comparable as a bioinformatics and multi-omics data platform serving the same scientific community Arcadia targets.

TypeEmerging player
Description

AI research lab building large language models of protein sequences inspired by evolutionary biology. Emerging peer with direct conceptual overlap to Arcadia's use of evolutionary data, though focused on protein design rather than organism selection.

TypeOthers
Description

Non-profit biomedical research institution specializing in mouse model organisms and human genomics. Comparable as an ecosystem player curating model organism data and supporting translational research, though a non-profit rather than a commercial competitor.

TypeOthers
Description

Non-profit research organization conducting open science in biology and neuroscience, releasing data and tools publicly. Adjacent peer that shares Arcadia's open-science philosophy and contributes model organism resources to the community.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arcadia Science

Drug Discovery & Biotechnology Research Softwarearcadia.science

Arcadia Science is a private Emeryville-based evolutionary biology company building Zoogle, an organismal search tool that uses billions of years of evolutionary data to predict the best research models for human biology, serving academic, pharma, and biotech researchers via an open-science distribution model.

What Arcadia Science does

Arcadia Science is an evolutionary biology company developing methods to predict and test therapeutics by leveraging billions of years of evolutionary data. The company is structured around the thesis that evolution itself is the world's largest R&D program and that its structure can be used to inform every stage of the drug development cycle — from organism selection to therapeutic hypothesis generation. The platform is horizontally aimed at the scientific research community, including academics, pharmaceutical companies, and biotech researchers who need better organism models for studying human biology.

The company's core product is Zoogle, a web portal launched in February 2025 that serves as an organismal search tool. Zoogle takes evolutionary data across species and uses it to predict which organisms are the most relevant biological models for different aspects of human biology. Beyond Zoogle, Arcadia releases software pipelines, apps, protocols, and other research resources under an open-science publishing model, distributing via GitHub, Substack, blog, and social channels. The stated revenue model is subscription/recurring for its research platform and tools, though pricing is not publicly disclosed and no specific paying customers are named.

Arcadia is incorporated as a private for-profit entity based in Emeryville, California (6401 Hollis Street, Suite 100), with 11–50 employees. Its leadership is composed of co-founders Seemay Chou (CEO), Prachee Avasthi (CSO and CSA), and Jed McCaleb (Co-Founder, Board Member and Advisor to the CEO) — a configuration that combines academic biology leadership with a high-profile technology entrepreneur. Most recently, the company announced two research partnerships in August 2025 to investigate predicted disease-organism matches, representing an early step from internal research toward externally-validated, partnership-driven use of its platform.

Arcadia Science firmographics

Firmographics
Name
Arcadia Science
Legal name
Arcadia Science
Website
https://arcadia.science
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Arcadia Science is a private Emeryville-based evolutionary biology company building Zoogle, an organismal search tool that uses billions of years of evolutionary data to predict the best research models for human biology, serving academic, pharma, and biotech researchers via an open-science distribution model.
Ownership category
akta.pro rank

Arcadia Science industry classification

Industry
Product category
Drug Discovery & Biotechnology Research Software
NAICS
Software Publishers (5132)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Evolutionary biology research
  • Drug discovery platform
  • Organismal search tools
  • Therapeutic prediction software
  • Open science publishing

Where Arcadia Science is headquartered

Location

Headquarters

HQ city
Emeryville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Arcadia Science business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Research Platform & Tools: Developing a platform for predicting and testing therapeutics based on evolutionary biology insights. The company releases tools, apps, and software pipelines to the scientific community, potentially through partnerships with pharmaceutical companies or research institutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Arcadia Science product offering

Product offering

Core offering

Arcadia Science develops Zoogle, a web portal that leverages billions of years of evolutionary data to help predict which organisms are the most relevant models for different aspects of human biology. The company is also building an evolutionary biology platform that uses the structure of evolution to inform efforts across the research and development cycle for predicting and testing therapeutics. It releases apps, software pipelines, protocols, and other resources to the scientific community as part of an open science approach.

Product overview

Arcadia Science is an evolutionary biology company developing better ways to predict and test therapeutics. Their main product is Zoogle, an organismal search tool. They also offer a platform for research and development, and release various tools including apps, software pipelines, and protocols to the scientific community as part of their open science approach.

Differentiator

Problem solved

Functional benefit

Brands

  • Zoogle: An organismal search tool that leverages billions of years of evolutionary data to help predict which organisms are the most relevant models for different aspects of human biology.

Products and services

  • Zoogle A web portal / organismal search tool that leverages billions of years of evolutionary data to help researchers predict which organisms are the most relevant models for different aspects of human biology. Intended for researchers in academic institutions, pharmaceutical companies, and biotech firms working on therapeutic prediction and model organism selection.

Companies that use Arcadia Science

Customer profile

Segments1 record

Ideal customer profiles1 record

Arcadia Science technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Arcadia Science partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Arcadia Science competitors and assessment

Company assessment

Direct peers

  • Recursion Pharmaceuticals: AI-driven drug discovery platform using high-throughput biology and computational tools to identify therapeutics. Direct peer because both target therapeutic prediction through biological data and computational methods, though Recursion is much larger and more capital-intensive.
  • Insitro: Machine learning-driven drug discovery company combining biology and AI to predict therapeutic outcomes. Comparable to Arcadia in its mission to use data-driven biology to inform drug development, though Insitro focuses on cell-based phenotypic data.
  • Isomorphic Labs: Alphabet/DeepMind spinoff applying AI to drug discovery with a focus on novel protein structure prediction. A direct competitor in AI-informed therapeutic development, though with vastly greater resources and a different core methodology.
  • Genesis Therapeutics: AI-native drug discovery company using graph neural networks and molecular simulation to predict drug behavior. Comparable in using computational methods to predict therapeutic properties and working with emerging biology.
  • Atomwise: AI-driven small molecule drug discovery company using structure-based design and prediction. Comparable in applying AI/ML to predict therapeutic candidates and inform R&D decisions.

Broad incumbents

  • Benchling: Cloud-based life sciences R&D platform serving biotech and pharma with informatics tools. Broader incumbent in life science software, relevant as a comparator for Arcadia's software platform ambitions in the research informatics space.
  • DNAnexus: Biomedical informatics and data management platform for genomics and clinical research. Comparable as a bioinformatics and multi-omics data platform serving the same scientific community Arcadia targets.

Emerging players

  • EvolutionaryScale: AI research lab building large language models of protein sequences inspired by evolutionary biology. Emerging peer with direct conceptual overlap to Arcadia's use of evolutionary data, though focused on protein design rather than organism selection.

Others

  • Jackson Laboratory (JAX): Non-profit biomedical research institution specializing in mouse model organisms and human genomics. Comparable as an ecosystem player curating model organism data and supporting translational research, though a non-profit rather than a commercial competitor.
  • Allen Institute: Non-profit research organization conducting open science in biology and neuroscience, releasing data and tools publicly. Adjacent peer that shares Arcadia's open-science philosophy and contributes model organism resources to the community.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Arcadia Science social profiles

Digital presence

Arcadia Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arcadia Science leadership team

Management profile

Number of profiles

Profiles3 records

Arcadia Science funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arcadia Science M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arcadia Science

What does Arcadia Science do?

Arcadia Science develops Zoogle, a web portal that leverages billions of years of evolutionary data to help predict which organisms are the most relevant models for different aspects of human biology. The company is also building an evolutionary biology platform that uses the structure of evolution to inform efforts across the research and development cycle for predicting and testing therapeutics. It releases apps, software pipelines, protocols, and other resources to the scientific community as part of an open science approach.

Is Arcadia Science a public or private company?

Arcadia Science is a private company. It is classified as unknown and is currently operating.

When was Arcadia Science founded?

Arcadia Science was founded in 2021. It employs 11 to 50 people.

Where is Arcadia Science based?

Arcadia Science is headquartered in Emeryville, United States, in the North America region.

How does Arcadia Science make money?

One revenue line is on record: research Platform & Tools.

Who are Arcadia Science's main competitors?

Direct peers on record are Recursion Pharmaceuticals, Insitro, Isomorphic Labs, Genesis Therapeutics and Atomwise. Broad incumbents are Benchling and DNAnexus. EvolutionaryScale is listed as an emerging player. Others are Jackson Laboratory (JAX) and Allen Institute.

Does Arcadia Science have an API?

No public API is recorded for Arcadia Science.

What industry is Arcadia Science in?

Arcadia Science's product category is Drug Discovery & Biotechnology Research Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization). Its NAICS code is 5132 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals